RosTrace

Robin Hayes

Latest from Robin Hayes

Robin Hayes

Disrupted Body Clocks Sharply Increase Risk of Early Death, Global Study Finds

Disruptions to the body’s internal clock — known as circadian rhythms — may significantly elevate the risk of premature death, according to a major new study published in Scientific Reports. Researchers analyzing data from large-scale U.S. and Chinese populations found that adults aged 40 and over with disrupted circadian rhythms faced heightened mortality from cardiovascular, metabolic, renal, and neurodegenerative diseases.

· 3 min read

Robin Hayes

New Biomarker Predicts Multiple Sclerosis Progression, Offering Hope for Better Treatment Strategies

Researchers at the University of Turku have identified a novel biomarker that may revolutionize how clinicians assess the progression and severity of multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system. The groundbreaking study, published in Nature Medicine, offers promising new directions for both targeted treatment and faster development of therapeutic drugs—particularly for progressive MS, which remains one of the most challenging forms of the disease to treat.

· 3 min read

Robin Hayes

US Scientists Warn of Looming Measles Crisis Amid Declining Vaccination Rates

The United States is inching dangerously close to a public health crisis as falling childhood immunization rates threaten to make measles endemic once again, scientists warn. A new study by researchers at Stanford University’s School of Medicine has modeled the long-term impact of declining vaccine coverage, revealing stark predictions if current trends persist.

· 5 min read

Robin Hayes

MD Anderson Trials Show Breakthrough Results at AACR Annual Meeting 2025

At the prestigious American Association for Cancer Research (AACR) Annual Meeting 2025, researchers from The University of Texas MD Anderson Cancer Center unveiled promising results from several pioneering clinical trials that could redefine treatment paradigms across multiple cancer types. The presentations, covering personalized vaccines, metastasis-directed radiation therapy, and engineered exosome therapeutics, signal major advances in personalized oncology and immunotherapy.

· 3 min read

Robin Hayes

Early Inflammation Confirmed in Mouse Model of Hereditary Paralysis, Offering New Clues for Neurodegenerative Diseases

A groundbreaking study from the University of Bonn and the German Center for Neurodegenerative Diseases (DZNE) has revealed that inflammation in the brain may play a central role in the early progression of spastic paraplegia type 15 (SPG15), a rare hereditary neurodegenerative disorder. Conducted using a genetically modified mouse model and published in the Journal of Experimental Medicine, the research provides compelling evidence that immune system overactivation precedes neuronal degeneration—findings that may also shed light on the pathology of diseases like Alzheimer's.

· 4 min read

Robin Hayes

NIH Study Uncovers How Inflammation Amplifies Pain from Touch and Heat

A groundbreaking study by scientists at the National Institutes of Health (NIH) has unveiled the underlying biological mechanisms that cause normally harmless sensations like heat and touch to become painful in the presence of inflammation. The findings, published by researchers from the National Center for Complementary and Integrative Health (NCCIH) and the National Institute of Dental and Craniofacial Research (NIDCR), may open the door to more precise treatments for chronic and inflammatory pain.

· 4 min read

Robin Hayes

New Biomarkers Identified for Early Detection of Gynecological Cancer

In a significant breakthrough in the battle against gynecological cancers, researchers from the University of Skövde, in collaboration with the University of Gothenburg and the Sahlgrenska Academy, have identified a new set of biomarkers that could dramatically improve early detection and diagnosis. This discovery may offer renewed hope for hundreds of thousands of women globally, particularly those diagnosed with ovarian and endometrial cancers, which are among the most challenging to detect in their early stages.

· 5 min read

Robin Hayes

Owlstone Medical Receives $2.3 Million Investment from Cystic Fibrosis Foundation to Develop Breath Test for Pseudomonas aeruginosa

Owlstone Medical, a global leader in breath-based diagnostics through its proprietary Breath Biopsy® platform, has announced an equity investment of up to $2.3 million USD (approximately £1.7 million) from the Cystic Fibrosis Foundation. The funding will be used to support the development of a non-invasive breath test for the detection of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF).

· 3 min read

Robin Hayes

Older Adults Thrive on Immunotherapy Despite Age Gaps

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors, despite the natural weakening of the immune system that occurs with age. This promising conclusion comes from a new study conducted by researchers at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Convergence Institute.

· 2 min read

Robin Hayes

STIs Are Rising in Australia — Can Anything Reverse the Trend?

Over the past 30 years, Australia has seen a troubling surge in sexually transmitted infections (STIs) such as chlamydia, gonorrhoea, and syphilis. Despite the availability of testing and treatment, these bacterial infections continue to climb — often silently and without immediate symptoms.

· 4 min read